Stroke Risk and Blood Clots in New Atrial Fibrillation
Part of Brain & nervous system, Heart & circulation clinical trials.
This study looks at stroke risk and blood clotting in people who have just been diagnosed with atrial fibrillation (AFib) that is not caused by a heart valve problem, and who have not yet taken blood thinners. It aims to better understand how blood clots form in this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a type of irregular heartbeat called non-valvular atrial fibrillation (AFib, not caused by a heart valve problem) and it's a new diagnosis.
- You have never taken a blood thinner (like warfarin, apixaban, rivaroxaban, or dabigatran) for your AFib.
- You do not have a mechanical heart valve or significant mitral valve disease.
- You have not had a stroke, heart attack, or blood clot in the past 3 months, and do not have other major health conditions like active cancer, kidney failure on dialysis, or liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication to prevent strokes and blood clots in people with atrial fibrillation (an irregular heartbeat) who cannot safely take standard blood thinners. The drug works by blocking a different clotting factor, which may lower bleeding risks.
This study tests a new blood thinner to prevent strokes and blood clots in people with atrial fibrillation (a common heart rhythm problem). You may qualify if you have atrial fibrillation and at least one risk factor for stroke, or if you've never taken a blood thinner before.
This registry study follows people with atrial fibrillation to learn which risk factors are linked to stroke or blood clots traveling through the body. Your information helps improve how doctors predict risk and choose prevention strategies.
This study tests the safety of a new blood thinner for people with atrial fibrillation (AFib) who need long-term stroke prevention. If you qualify, the study will compare this medication to standard anticoagulation therapy.
This study tests whether patients with atrial fibrillation (a heart rhythm disorder) who have had both a previous brain bleed and a recent stroke can safely take blood thinners to prevent future strokes. Researchers want to find the safest approach for people in this high-risk situation.
This trial tests whether taking a blood thinner can lower the risk of stroke in people who had atrial fibrillation (an irregular heartbeat) that happened temporarily around a stressful illness or surgery. It looks especially at people at higher risk for stroke after that episode.
Hear when a new Atrial Fibrillation (Prevention of Stroke) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.